Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

Lab Relocation Specialist Expands Turnkey Solution

Published: Friday, March 07, 2014
Last Updated: Friday, March 07, 2014
Bookmark and Share
Specialist laboratory relocation expert, Andrew Porter Limited, has further expanded its service portfolio.

Specialist laboratory relocation expert, Andrew Porter Limited, has further expanded its service portfolio.

It anticipates that its two latest services will increase its market share throughout Europe and further reinforce its claim to provide the ‘gold standard’ for laboratory relocations.

Andrew Porter Limited, headquartered in the UK, can now support the revalidation of assays and provide independent third party laboratory audits to GLP/GCP standard.  Both these additional services underpin the company’s extensive and unique service proposition.

Renowned for its quality of staff training and strict adherence to regulatory standards, as well as its specialist integration of services, the firm is the only one of its type operating in Europe to comply with GxP standards.

European sales director, John Best, explained why Andrew Porter Limited’s services are held in such high regard within the industry.

“It is well known that relocating a laboratory environment is not a straight forward process, but the fact is that choosing an inexperienced relocations provider can lead to devastating consequences,” he said.

“Our focus is primarily on regulatory adherence, as well as reducing laboratory downtime, which has a potential impact on time to market.  We also manage the physical aspect of moving a laboratory, which can be incredibly complex when relocating high value, sensitive instrumentation at the same time as temperature controlled materials, data and dangerous goods.” 

He continued: “Being able to assist customers to re-establish and revalidate assays alongside the process required for instrumentation, as well as offering our CRO customers valuable independent third party auditing opportunities, will help us to deliver truly turnkey solutions way beyond many of the primitive removal services for labs which currently exist in the market place.

“Our network is expanding globally as we convert projects throughout Europe and we are striving to deliver a mature and technically driven service that can match this need as we grow.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Long-Sought Protein Sensor for the ‘Sixth Sense’ Discovered
In a study led by scientists from The Scripps Research Institute (TSRI)the sensor protein for propioception has been identified.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos